Icariin NEW
| Price | $33 | $47 | $67 |
| Package | 50mg | 100mg | 200mg |
| Supply Ability: | 10g |
| Update Time: | 2026-05-24 |
Product Details
| Product Name: Icariin | CAS No.: 489-32-7 |
| Purity: 98.49% | Supply Ability: 10g |
| Release date: 2026/05/24 |
Product Introduction
Bioactivity
| Name | Icariin |
| Description | Icariin (Ieariline) belongs to the flavonol glycoside group of natural products, can inhibit PDE5 and PDE4 activity (IC50=432/73.50 μM), is also a PPARα activator. Icariin can increase cardiovascular and cerebrovascular blood flow, promote hematopoiesis, immunity and bone metabolism. |
| In vitro | METHODS: Osteoarthritic fibroblast-like synoviocytes OA-FLSs were treated with Icariin (0.1-10 μM) for 12 h, and cell viability was measured using MTS assay. RESULTS: No cytotoxic effect of Icariin at 0.1-1 μM was observed in OA-FLSs. At a concentration of 10 μM, Icariin showed low cytotoxicity to OA-FLSs, which significantly inhibited the proliferation of OA-FLSs after 12 h. The results showed that Icariin was not effective in inhibiting the proliferation of OA-FLSs after 12 h of treatment. [1] METHODS: Fibroblast-like synoviocyte FLSs were treated with Icariin (1-5 μM) for 24-36 h. Cell migration was detected using the Wounding migration assay and Transwell chamber assay. RESULTS: Wound closure was significantly slowed in FLS treated with Icariin, and Transwell chamber assay showed that Icariin inhibited FLS migration in a concentration-dependent manner. [2] |
| In vivo | METHODS: To investigate the protective effects against traumatic brain injury (TBI), Icariin (3-30 mg/kg) was administered orally twice daily for seven days to a mouse model of TBI induced by controlled cortical impact. RESULTS: The Icariin 30 mg/kg and 10 mg/kg treatment groups showed enhanced sensorimotor function 8 days after TBI in the rotating bar and balance beam tests.The Icariin treatment group showed an increase in recognition indices in the novel object recognition test at all doses, and an increase in spontaneous alternation in the Y maze test in the 30 mg/kg group.Icariin upregulated the expression of brain-derived neurotrophic factor, synaptophysin, and postsynaptic density protein 95. However, no protective effect against brain injury or neuronal death was observed. [3] |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
| Solubility Information | 10% DMSO+40% PEG300+5% Tween 80+45% Saline : 6 mg/mL (8.87 mM), Solution. H2O : < 1 mg/mL (insoluble or slightly soluble) Ethanol : < 1 mg/mL (insoluble or slightly soluble) DMSO : 245 mg/mL (362.07 mM), Sonication is recommended. |
| Keywords | PPAR | Phosphodiesterase (PDE) | phosphodiesterase | Peroxisome proliferator-activated receptors | PDE5 | Inhibitor | inhibit | Icariin | Autophagy |
| Inhibitors Related | Stavudine | Aceglutamide | Hemin | Tamoxifen | D(+)-Raffinose pentahydrate | Guanidine hydrochloride | Hydroxychloroquine | Daidzein | Paeonol | Naringin | Alginic acid | Sildenafil citrate |
| Related Compound Libraries | Highly Selective Inhibitor Library | Flavonoid Natural Product Library | Traditional Chinese Medicine Monomer Library | Bioactive Compound Library | Anti-Neurodegenerative Disease Compound Library | Anti-Cancer Clinical Compound Library | Natural Product Library | Drug Repurposing Compound Library | Inhibitor Library | Natural Product Library for HTS | Immunology/Inflammation Compound Library | Bioactive Compounds Library Max |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
Recommended supplier
| Product name | Price | Suppliers | Update time | |
|---|---|---|---|---|
|
VIP6Y
|
WUHAN FORTUNA CHEMICAL CO., LTD
|
2026-07-10 | ||
| $10.00 |
VIP6Y
|
RongNa Biotechnology Co.,Ltd
|
2026-07-09 | |
| $5.00 |
VIP3Y
|
Henan Fengda Chemical Co., Ltd
|
2026-07-09 | |
|
VIP5Y
|
Changsha Staherb Natural Ingredients Co., Ltd.
|
2026-07-07 | ||
|
VIP6Y
|
Sinoway Industrial co., ltd.
|
2026-07-02 | ||
|
VIP2Y
|
Shaanxi Dideu New Materials Co. Ltd
|
2026-06-30 | ||
|
VIP3Y
|
Chongqing Zhihe Biopharmaceutical Co., Ltd.
|
2026-06-29 | ||
|
VIP1Y
|
Jinan Ruitong Biotech Co., Ltd.
|
2026-06-08 | ||
|
VIP3Y
|
BINBO BIOLOGICAL CO.,LTD
|
2026-05-22 | ||
| $4687.00 |
VIP6Y
|
Baoji Guokang Healthchem Co., Ltd.
|
2026-05-15 |
United States- Since: 2011-01-07
- Address: 36 Washington Street, Wellesley Hill, MA
INQUIRY